blood-brain barrier drugs

‘Antidepressant Shows Promise in Glioblastoma Treatment’: ETH Zurich Research

Glioblastoma, one of the most aggressive forms of brain tumors, remains largely incurable. Despite the use of surgeries, radiation, and chemotherapy, half of all glioblastoma patients succumb within a year of diagnosis. A major challenge in treating these tumors is the difficulty in finding medications that can cross the blood-brain...